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Depigmented haloes sometimes appear around melanocytic tumors or non-melanocytic tu-
mors, but coexistence of warts and depigmented haloes is extremely rare. We report here an 
unusual case of warts accompanied by depigmented haloes and subsequently-triggered gener-
alized vitiligo. A 55-year-old Japanese man presented with a 3-year history of brown nodules 
on the back, upper eyelid and dorsum of the left hand. Depigmented haloes appeared around 
the noldules and then gradually spread over a wide area, resulting in the development of gen-
eralized vitiligo. He had no history of antecedent treatment for these lesions before consulta-
tion. Histopathologically, the lesion showed papillomatosis and hyperkeratosis with lympho-
cytic exocytosis into the epidermis, which compatible to warts. Based on these clinical and his-
topathologic findings, a diagnosis of warts with depigmented halo and subsequently-triggered 
generalized vitiligo was made. None of the warts had resolved spontaneously after the appear-
ance of haloes, and the depigmented haloes and generalized vitiligo remain unchanged.
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Depigmented haloes sometimes appear around 
melanocytic tumors such as melanocytic nevi and 
malignant melanomas. Although there have been 
sporadic patient reports on this phenomenon in non-
melanocytic lesions, coexistence of warts and de-
pigmented haloes is extremely rare. We report here 
an unusual case of warts accompanied by depig-





A 55-year-old Japanese man presented with a 3-year 
history of brown nodules. He had felt pruritus in 
the nodules 3 weeks before consultation. Depig-
mented haloes appeared around the noldules and 
then gradually spread over a wide area, resulting 
in the development of generalized vitiligo. He had 
no history of autoimmune diseases and family his-
tory of vitiligo. Physical examination revealed a 
relatively elevated, flat-topped verrucous nodule 
on the left upper eyelid. It was 7 mm in size and 
the surface was papillomatous (Fig. 1). Results of 
routine laboratory studies were unremarkable. Der-
moscopic examination revealed exophytic papillary 
structures with hyperkeratosis and dotted vessels in 
the tops of dermal papillae. Similar nodules were 
observed on the left face, upper part of the back and 
dorsum of the left hand. Most of the nodules were 
accompanied by depigmented haloes. Generalized 
vitiligo was also seen (Fig. 2). He underwent skin 
biopsy of the verrucous nodule with a depigmented 
halo on the dorsum of the left hand as a representa-
tive lesion. Histopathologically, the lesion showed 
papillomatosis and hyperkeratosis with lymphocytic 
exocytoses into the epidermis. In addition, there 
were superficial lymphocytic infiltrate in the der-
mis. Based on these clinical and histopathologic 
findings, a diagnosis of warts with depigmented 
halo and subsequently-triggered generalized vitiligo 
was made. None of the warts had resolved spon-
taneously after the appearance of haloes. Residual 
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warts were treated with cryotherapy, and most of 
them consequently showed involution. However, the 
depigmented haloes and generalized vitiligo remain 




Some non-melanotic lesions are known to be asso-
ciated with depigmented haloes, but warts with ha-
loes are extremely rare (Berman, 1977); there have 
been only 2 cases in a previous literature. Berman 
reported that depigmented haloes developed around 
involuting flat warts in 2 patients whose warts were 
treated with a 6% salicylic acid-propylene glycol gel 
formulation (Berman, 1977). In those patients, all 
of the warts disappeared soon after the appearance 
of depigmented haloes, but generalized vitiligo was 
not found. 
 There are 2 different points between our pa-
tient and previous ones (Berman, 1977); the pres-
ence of antecedent treatment and generalized vit-
iligo. Berman used salicylic acid-propylene glycol 
gel for treatment of the warts. Some topical agents, 
such as imiquimod and diphenylcyclopropenone, 
have been reported to induce depigmented vitiligo 
(Serrão et al., 2008; Oh et al., 2012). These agents 
are thought to activate host immune reactions. Al-
though Berman confirmed that the gel did not in-
Fig. 2. Many verrucous nodules with depigmented haloes 
and generalized vitiligo on the upper part of the back (ar-
rows).
Fig. 1. A verrucous nodule with a depigmented halo on 
the left upper eyelid.
duce depigmentation in some healthy people, there 
remains the possibility of an association between 
the gel and depigmentation. However, no antecedent 
topical agent was used in our patient.
 Pathogenesis of the halo phenomenon is still 
unclear. However, it seems that vitiligo lesion on the 
back in our patient is composed of multiple depig-
mented haloes. Because a large number of lympho-
cytes had infiltrated into the verrucous lesion in our 
biopsied specimen, both depigmented haloes and 
generalized vitiligo might have been elicited by host 
reaction, leading to the decrease of melanocytes. It 
is of interest that our patient had generalized vitiligo 
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